 |
Synthetic derivative of 16-hydroxy-9Z, 12Z, 14E-octadecatrienoic acid |
|---|---|
| Trade Name | Drepanol |
| Orphan Indication | Prophylactic treatment of sickle cell disease |
| USA Market Approval | USA |
| USA Designation Date | 1991-10-24 00:00:00 |
| Sponsor | Omex International, Inc.;6001 Savoy, Suite 110;Houston, Texas, 77036 |
